TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells

Kidney International

Volumn 56, Issue 3, 1999, Pages 985-994

  Banu, Nazifa ^a   Meyers, Catherine M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Class II transactivator; Lipopolysaccharide; Renal immune response; T lymphocytes; Transforming growth factor

Indexed keywords

B7 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; HLA ANTIGEN CLASS 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; IMMUNE RESPONSE; KIDNEY DISEASE; KIDNEY TUBULE EPITHELIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE; GENETICS; IMMUNOLOGY; KIDNEY TUBULE; METABOLISM; TRANSACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CELLS, CULTURED; DOWN-REGULATION; EPITHELIAL CELLS; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA, RECOMBINANT; KIDNEY TUBULES; LIPOPOLYSACCHARIDES; MICE; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA;

EID: 0032586745     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00645.x     Document Type: Article

References (57)

1. 1. Wofsy D, Ledbetter JA, Hendler PL, Seaman WE: Treatment of murine lupus with monoclonal anti T-cell antibody, J Immunol 134:852-857, 1985
2. 2. Reynolds J, Pusey CD: In vivo experiment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat. Clin Exp Immunol 95:122-127, 1994
3. 3. Meyers CM: T-cell regulation of renal immune responses. Curr Opin Nephrol 4:270-276, 1995
4. 4. Lan HY, Paterson DJ, Atkins RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40:425-433, 1991
5. 5. Swain SI: T cell subsets and the recognition of MHC class. Immunol Rev 74:129-142, 1983
6. 6. Collins TL, Kassner PD, Bierer BE, Burakoff SJ: Adhesion receptors in lymphocyte activation. Curr Opin Immunol 6:385-393, 1994
7. 7. Croft M, Dubey C: Accessory molecule and costimulation requirements for CD4 T cell response. Crit Rev Immunol 17:89-118, 1997
8. 8. Haverty TP, Watanabe M, Neilson EG, Kelly CJ: Protective modulation of class II MHC gene expression in tubular epithelium by target antigen-specific antibodies. Cell-surface directed down-regulation of transcription can influence susceptibility to murine tubulointerstitial nephritis. J Immunol 143:1133-1141, 1989
9. 9. Wuthrich RP, Yui MA, Mazoujian G, Nabavi N, Glimcher LH, Kelly VE: Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am J Pathol 134:45-51, 1989
10. 10. Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P: Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 141:2303-2312, 1988
11. 11. Banu N, Meyers CM: IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells. Kidney Int 55:2250-2263, 1999
12. 1. Suppression of a nephritogenic murine T cell clone. Kidney Int 46:1295-1301, 1994
13. 13. Takeuchi M, Alard P, Streilein JW: TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 160:1589-1597, 1998
14. 14. Devaiyothi C, Kalvakolanu I, Babcock GT, Vasavada HA, Howe PH, Ransohoff RM: Inhibition of IFN-γ-induced major histocompatibility complex class II gene transcription by IFN-β and type β1 transforming growth factor in human astrocytoma cells: Definition of cis-clement. J Biol Chem 268:18794-18800, 1993
15. 15. Frei K, Lins M, Schwerdel C, Fontana A: Antigen presentation in the central nervous system: The inhibitory effect of IL-10 on class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 152:2720-2728, 1994
16. 16. Sporn MB, Roberts AB: TGF-β: Problems and prospects. Cell Regul 1:875-882, 1990
17. 17. Massague J: The transforming growth factor-β family. Ann Rev Cell Biol 6:597-641, 1990
18. 18. Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, Mcdean DJ, Abraham RT: Regulatory effects of transforming growth factor-β on IL-2 and IL-4-dependent T cell-cycle progression. J Immunol 144:1767-1776, 1990
19. 19. Kehrl JH, Taylor A, Kim SJ, Fauci AS: Transforming growth factor-β is a potent negative regulator of human lymphocytes. Ann NY Acad Sci 628:345-353, 1991
20. 20. Letterio JJ, Roberts AB: Regulation of immune responses by TGF-β. Ann Rev Immunol 16:137-161, 1998
21. 21. Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB, Sporn AB: Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc Natl Acad Sci USA 90:9944-9948, 1993
22. 22. Letterio JJ, Geiser AG, Kulkarni AB, Dang H, Kong L, Nakabayashi T, Mackall CL, Gress RE, Roberts AB: Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest 98:2109-2119, 1996
23. 23. Meyers CM, Tomaszweski JE, Glass JD, Chen CW; The nephritogenic T cell response in murine chronic graft-vs-host disease. J Immunnol 10:5321-5330, 1998
24. 24. Taub M, Sato G: Growth of functional primary cultures of kidney epithelial cells in defined medium. J Cell Physiol 105:369-378, 1980
25. 25. Sims TN, Elliott JF, Ramassar V, Denny DW, Halloran PF: Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator. Immunogenetics 45:220-222, 1997
26. 26. Horley KJ, Carpenito C, Baker B, Takei F: Molecular cloning of murine intercellular adhesion molecule (ICAM-1). EMBO J 8-2889-2896, 1989
27. 27. Hemmi S, Bohni R, Stark G, Di Macro F, Aguet M: A novel member of the interferon receptor family complements functionality of the murine interferon-γ receptor in human cells. Cell 76:803-810, 1994
28. 28. Alonso S, Minty A, Bourlet Y, Buckingham M: Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 23:11-22, 1986
29. nd ed). New York, John Wiley & Sons, Inc., 1994
30. 30. Armitage P, Berry G: Statistical Methods in Medical Research. Boston, Blackwell Scientific Publication, Inc., 1987, p 559
31. 31. Steimle V, Siegrist C-A, Motiet A, Lisowska-Grospierre B, Mach B: Regulation of class II MHC expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106-109, 1994
32. 32. Ramassar V, Goes N, Hobart M, Halloran PF: Evidence for the in vivo role of class II transactivator in basal and IFN-γ induced class II expression in mouse tissue. Transplantation 62:1901-1907, 1996
33. 33. Chang C-H, Fontes JD, Peterlin M, Flavel RA: Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180:1367-1374, 1994
34. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol 155:45-56, 1995
35. 35. Townsend SE, Allison JP: Tumor rejection after direct costimulation of CD8' T cells by B7-transfected melanoma cells. Science 259:1093-1095, 1993
36. 36. Shrikant P, Lee SJ, Kalvakolanu I, Ransohoff RM, Benveniste EN: Stimulus-specific inhibition of intercellular adhesion molecule-1 gene expression by TGF-β. J Immunol 157:892-900, 1996
37. 37. Pernis A: Lack of interferon-γ receptor β chain and the prevention of interferon-γ signaling in Th1 cells. Science 269:245-247, 1995
38. 38. Pinson DM, Leclaire RD, Lorsbach RB, Parmely MJ, Russell SW: Regulation by transforming growth factor-β1 of expression and function of the receptor for IFN-γ on mouse macrophages. J Immunol 149:2028-2034, 1992
39. 39. Hagerty DT, Allen PM: Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 148-2324-2330, 1992
40. 40. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe, M, Harper RA, Kefalides NA, Neilson EG: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107:1359-1368, 1988
41. 41. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE: MHC: class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37:783-792, 1990
42. 42. Wuthrich RP, Jevnikar AM, Takei F, Glimcher LH, Kelly VE: Intercellular adhesion molecule-1 (ICAM-1) is upregulated in autoimmune lupus nephritis. Am J Pathol 136:441-450, 1990
43. 43. Wuthrich RP: Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol 3:1201 1211, 1992
44. 44. Zuber P, Kuppner MC, De Tribolet N: Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 18:1623-1626, 1988
45. 45. Panyk RB, Lee Y-J, Benveniste EN: TGF-β suppression of IFN-γ-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-γ enhanced factor X expression. J Immunol 154:610-619, 1995
46. 46. Cross D, Cambier JC: Transforming growth factor β1 has differential effects on B cell proliferation, activation, and antigen expression. J Immunol 144:432-439, 1990
47. 47. Nandan D, Reiner NE: TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J Immunol 158:1095-1101, 1997
48. 48. Lee Y-J, Han Y, Lu H-T, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN: TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol 158:2065-2075, 1997
49. 49. Frishberg Y, Meyers CM, Kelly CJ: Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. Kidney Int 50:45-53, 1996
50. 50. Gamble JR, Bradley S, Noack L, Vadas MA: TGF-β and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells, Arterioscler Thromb Vasc Biol 15:949-955, 1995
51. 51. Swerlick RA, Garcia-Gonzalez, E, Kubota Y, Xu Y, Lawley TJ: Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol 97:190-196, 1991
52. 52. Barlett WC, Purchio A, Fell HP, Noelle RJ: Cognate interactions between helper T cells and B cells. V1. TGF:-beta inhibits B cell activation and antigen-specific, physical interactions between Th and B cells. Lymphokine Cytokine Res 10:177-183, 1991
53. 53. Sharma K, Ziyadeh F: Renal hypertrophy is associated with upregulation of TGF-beta I gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1994
54. 54. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti F: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
55. 55. Bottinger EP, Kopp JB: Lessons from TGF-β transgenic mice, Miner Electrol Metab 24:154-160, 1998
56. 56. RACKE MK, DHIB-JALBUT S, CANNELLA B, ALBERT PS, RAINE CS, MCFARLIN DE: Prevention and treatment of chronic relapsing experimental allergic encephalomyclitis by transforming growth factor-β. J Immunol 146:3012-3017, 1991
57. 57. Brandes AE, Allen JB, Ogawa Y, Wahl SM: Transforming growth factor-β1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 87:1108-1113, 1991